Skip to content
[ivory-search id="184" title="Recordati AJAX Search Form"]
Our Offices
Careers
Contact Us
Italiano
English
Company
Open menu
Company Block 1
Who we are
Open menu
Our Story
Open menu
Company Block 2
Leadership
Open menu
Partnering
Open menu
Governance
Open menu
governance block 1
Corporate Governance
Open menu
Corporate Governance Report
Open menu
Company Bylaws
Open menu
Board of Directors
Open menu
Board of statutory auditors
Open menu
governance block 2
Committees
Open menu
Firm of Auditors
Open menu
Remuneration
Open menu
Internal Dealing
Open menu
governance block 3
Share buy-back
Open menu
Compliance Programmes
Open menu
Other Corporate documents
Open menu
Contact
Open menu
Business
Open menu
business block 1
Operations & Businesses
Open menu
Specialty & Primary care
Speciality & Primary care – Products
Open menu
Open menu
Rare diseases
Rare diseases – Products
Open menu
Open menu
business block 2
Industrial Operations
Open menu
Research & Development
Open menu
Chemicals Business
Open menu
Investors
Open menu
Investor block 1
Investor Relations
Open menu
Presentations & Reports
Open menu
Share Price
Open menu
Investor Events
Open menu
Investor Block 2
Shareholder Information
Open menu
Analyst Coverage
Open menu
Company Announcements
Open menu
Investor Block 3
Public Tender Offers
Open menu
Regulated information service providers
Open menu
Contacts
Open menu
Sustainability
Open menu
Sustainability Block 1
Our Commitment
Open menu
Sustainability
plan
Open menu
Main ESG Indices & ratings
Open menu
Sustainability Block 2
Patient Care
Open menu
Our People
Open menu
Environmental Protection
Open menu
Sustainability Block 3
Ethics & Integrity
Open menu
Growing with Suppliers
Open menu
Community
Open menu
Contacts & Documents
Open menu
People
Open menu
Careers Block 1
Unlocking Potential
Open menu
Supporting education & research
Open menu
Join our team
Open menu
Media
Open menu
Investor Category:
Company Presentations
2024, 8 November- First Nine Month Results 2024 (Presentation)
2024, October 4 – Acquisition of global rights to Enjaymo
2024, September 20 – Latest Company Presentation
2024, 30 July – First Half Year Results 2024 (Recording and Transcript)
2024, May 9 – 2024 First Quarter Results (Transcript and Recording)
2024, January 10 – J.P Morgan Healthcare Conference Presentation
Transcript and Recording – 2024, February 22 – 2023 Preliminary Full-Year Results
2023, 7 November – First Nine Month Results 2023
Investor – Company Presentation – Financial First Half Year Results
Company Presentations – 2023 First quarter results
Posts navigation
Page 1
…
Page 17
Older
posts